Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01876069 | Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer | completed | N/A | 65 | Samsung Medical CenterOTHER | 1 | Apr 27, 2016 | clinicaltrials |
| NCT00402025 | Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 | 17 | BioVex LimitedINDUSTRY | 1 | Apr 15, 2016 | clinicaltrials |
| NCT01814631 |
| Endoscopic Ultrasound (EUS) Processor Comparison |
| withdrawn |
| — |
| 0 |
| AdventHealthOTHER |
| 1 |
| Apr 14, 2016 |
| clinicaltrials |
| NCT02068677 | Evaluation of Injection Techniques in Celiac Plexus Neurolysis | completed | N/A | 51 | AdventHealthOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02550847 | Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT01446952 | Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT01395017 | Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer(LAPC) | completed | Phase 2 | 202 | Otsuka Pharmaceutical Development & Commercialization, Inc.INDUSTRY | 15 | Apr 8, 2016 | clinicaltrials |
| NCT02423239 | A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours | unknown | Phase 1 | 112 | e-Therapeutics PLCINDUSTRY | 4 | Apr 6, 2016 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT01296763 | Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 18 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01446458 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | completed | Phase 1 | 13 | Emory UniversityOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01962909 | Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer | terminated | Early Phase 1 | 3 | University of VirginiaOTHER | 1 | Mar 18, 2016 | clinicaltrials |
| NCT01274455 | Gene Therapy of Pancreatic Ductal Adenocarcinoma(TherGAP) | completed | Phase 1 | 22 | University Hospital, ToulouseOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT02707315 | A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | unknown | Early Phase 1 | 15 | The Cooper Health SystemOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT02706782 | A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma(meso-CART) | unknown | Phase 1 | 30 | Shanghai GeneChem Co., Ltd.INDUSTRY | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00383149 | A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer | completed | Phase 2 | 58 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00897494 | Identification of Biomarkers for Early Detection of Pancreatic Cancer | completed | — | 75 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 9, 2016 | clinicaltrials |
| NCT01658943 | Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy(S1115) | completed | Phase 2 | 137 | National Cancer Institute (NCI)NIH | 1 | Mar 9, 2016 | clinicaltrials |
| NCT00375310 | Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer | completed | Phase 1 | 27 | Indiana UniversityOTHER | 1 | Feb 29, 2016 | clinicaltrials |
| NCT02079285 | Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation(FNASROSE) | completed | — | 75 | Kangbuk Samsung HospitalOTHER | 1 | Feb 24, 2016 | clinicaltrials |
| NCT00587964 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT02685228 | Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer(SLOWDOSE001) | unknown | N/A | 20 | The First Hospital of Jilin UniversityOTHER | 0 | Feb 18, 2016 | clinicaltrials |
| NCT02682394 | Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas | unknown | — | 30 | Soroka University Medical CenterOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT01509911 | A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment | unknown | Phase 2 | 99 | Tiltan Pharma Ltd.INDUSTRY | 2 | Feb 5, 2016 | clinicaltrials |
| NCT00994110 | Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess | completed | Phase 3 | 439 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT02670265 | Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions(NUPAN) | completed | N/A | 100 | University Medicine GreifswaldOTHER | 0 | Feb 1, 2016 | clinicaltrials |
| NCT00580021 | Clinical Outcomes in Hereditary Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT01801852 | Autologous Natural Killer T Cells Infusion for the Treatment of Cancer | unknown | N/A | 300 | Chinese PLA General HospitalOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02662348 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | unknown | Phase 1 | 6 | Yi MiaoOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00008099 | Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 1 | 25 | University of PittsburghOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT00003411 | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Jan 18, 2016 | clinicaltrials |
| NCT00851955 | Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer | completed | — | 150 | Mayo ClinicOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT02646462 | Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer | unknown | — | 200 | Michael Bau MortensenOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT02028845 | Loop-tipped Guidewire in Selective Biliary Cannulation | completed | N/A | 200 | Ajou University School of MedicineOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT00574977 | Safety Study of Modified Vaccinia Virus to Cancer | completed | Phase 1 | 26 | David BartlettOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT02637596 | Quality of Life After Radiofrequency Ablation of Pancreatic Cancer | completed | N/A | 1 | Brno University HospitalOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00100815 | Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer | completed | Phase 2 | 50 | Roswell Park Cancer InstituteOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00548626 | Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer(EMUNE-07) | completed | N/A | 47 | University of ChicagoOTHER | 1 | Dec 21, 2015 | clinicaltrials |
| NCT02634502 | Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Dec 18, 2015 | clinicaltrials |
| NCT00634725 | Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 3 | 820 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT02133079 | Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 20 | Cure&Sure Biotech Co., LTDINDUSTRY | 1 | Dec 11, 2015 | clinicaltrials |
| NCT00843830 | A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma | terminated | Phase 1 | 4 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 8, 2015 | clinicaltrials |
| NCT00864513 | Study of Pemetrexed for Second-Line Pancreas Cancer | terminated | Phase 2 | 17 | Georgetown UniversityOTHER | 1 | Dec 8, 2015 | clinicaltrials |
| NCT00456599 | Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer | completed | Phase 2 | 71 | University of Michigan Rogel Cancer CenterOTHER | 2 | Dec 3, 2015 | clinicaltrials |
| NCT00898482 | Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants | completed | — | 88 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 0 | Nov 20, 2015 | clinicaltrials |
| NCT00005832 | S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 58 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00075686 | S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer | completed | Phase 3 | 766 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Apr 27, 2016source: clinicaltrials